Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients (Q83186748)
Jump to navigation
Jump to search
scientific article published on 29 March 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients |
scientific article published on 29 March 2006 |
Statements
Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients (English)
William T Abraham
Alireza A Shamshirsaz
Kim McFann
29 March 2006